$337.3 M

ASTS Mkt cap, 14-Jan-2022

$2.8 M

AST&Science Revenue Q2, 2021
AST&Science Gross profit (Q2, 2021)1.7 M
AST&Science Gross profit margin (Q2, 2021), %59.9%
AST&Science Net income (Q2, 2021)-65.2 M
AST&Science Cash, 30-Jun-2021402.6 M
Get notified regarding key financial metrics and revenue changes at AST&ScienceLearn more
Banner background

AST&Science Income Statement

Annual

USDFY, 2020

Operating expense total

384.9k

Pre tax profit

(2.7m)

Income tax expense

174.3k

Net Income

(2.9m)

EPS

(0.6)

Quarterly

USDQ1, 2021Q2, 2021

Revenue

2.8m

Cost of goods sold

1.1m

Gross profit

1.7m

Gross profit Margin, %

60%

R&D expense

9.1m

General and administrative expense

9.2m

Operating expense total

1.4m25.1m

Depreciation and amortization

567.0k

Interest income

6.0k

Pre tax profit

614.4k(65.1m)

Income tax expense

17.3k56.0k

Net Income

597.1k(65.2m)

EPS

0.0(0.4)

AST&Science Balance Sheet

Annual

USDFY, 2020

Cash

131.2k

Prepaid Expenses

23.3k

Current Assets

208.9k

Total Assets

232.4m

Accounts Payable

634.3k

Current Liabilities

634.3k

Total Liabilities

76.8m

Common Stock

1.6k

Additional Paid-in Capital

59.8m

Retained Earnings

(54.8m)

Total Equity

5.0m

Financial Leverage

46.5 x

Quarterly

USDQ1, 2021Q2, 2021

Cash

50.1m402.6m

Accounts Receivable

1.3m

Prepaid Expenses

47.7k5.6m

Inventories

3.7m

Current Assets

50.2m414.6m

PP&E

54.3m

Goodwill

3.8m

Total Assets

282.1m482.7m

Accounts Payable

1.3m6.3m

Current Liabilities

1.9m15.6m

Total Liabilities

126.0m137.5m

Common Stock

1.6k18.0k

Additional Paid-in Capital

59.2m168.3m

Retained Earnings

(54.2m)(71.5m)

Total Equity

5.0m345.2m

Financial Leverage

56.4 x1.4 x

AST&Science Cash Flow

Annual

USDFY, 2020

Net Income

(52.0m)

Accounts Payable

394.1k

Cash From Operating Activities

(862.6k)

Cash From Investing Activities

500.6k

Net Change in Cash

(362.0k)

Quarterly

USDQ1, 2021Q2, 2021

Net Income

597.1k(77.3m)

Depreciation and Amortization

1.2m

Accounts Receivable

748.0k

Inventories

(1.2m)

Accounts Payable

624.0k112.0k

Cash From Operating Activities

(862.2k)(38.4m)

Purchases of PP&E

(7.0m)

Cash From Investing Activities

303.2k(18.6m)

Cash From Financing Activities

50.5m416.9m

Net Change in Cash

49.9m359.8m

AST&Science Ratios

USDFY, 2020

Financial Leverage

46.5 x